ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palange, P.
Right arrow Articles by Bonsignore, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palange, P.
Right arrow Articles by Bonsignore, M. R.
Eur Respir J 2006; 27:529-541
Copyright ©ERS Journals Ltd 2006

Circulating haemopoietic and endothelial progenitor cells are decreased in COPD

P. Palange1, U. Testa2, A. Huertas1, L. Calabrò2, R. Antonucci1, E. Petrucci2, E. Pelosi2, L. Pasquini2, A. Satta3, G. Morici4,6, M. A. Vignola5,6 and M. R. Bonsignore5,6

1 Dipartimento di Medicina Clinica, University La Sapienza, and 2 Istituto Superiore di Sanita', Rome, and 3 Fondazione Maugeri, Tradate, Varese, and 4 Dept of Experimental Medicine, and 5 Institute of Medicine and Pneumology, University of Palermo, and 6 IBIM-CNR, Palermo, Italy.

CORRESPONDENCE: P. Palange, Dipartimento di Medicina Clinica, University La Sapienza, Viale Università 37, Rome, 00185 Italy. Fax: 39 064940421. E-mail: paolo.palange{at}uniroma1.it

Keywords: CD34+ cells, chronic obstructive pulmonary disease, exercise, growth factors, hypoxia

Received: October 22, 2004
Accepted October 15, 2005

Circulating CD34+ cells are haemopoietic progenitors that may play a role in tissue repair. No data are available on circulating progenitors in chronic obstructive pulmonary disease (COPD).

Circulating CD34+ cells were studied in 18 patients with moderate-to-severe COPD (age: mean±SD 68±8 yrs; forced expiratory volume in one second: 48±12% predicted) and 12 controls, at rest and after endurance exercise. Plasma concentrations of haematopoietic growth factors (FMS-like tyrosine kinase 3 (Flt3) ligand, kit ligand), markers of hypoxia (vascular endothelial growth factor (VEGF)) and stimulators of angiogenesis (VEGF, hepatocyte growth factor (HGF)) and markers of systemic inflammation (tumour necrosis factor (TNF)-{alpha}, interleukin (IL)-6, IL-8) were measured.

Compared with the controls, the COPD patients showed a three-fold reduction in CD34+ cell counts (3.3±2.5 versus 10.3±4.2 cells·µL–1), and a 50% decrease in AC133+ cells. In the COPD patients, progenitor-derived haemopoietic and endothelial cell colonies were reduced by 30–50%. However, four COPD patients showed progenitor counts in the normal range associated with lower TNF-{alpha} levels. In the entire sample, CD34+ cell counts correlated with exercise capacity and severity of airflow obstruction. After endurance exercise, progenitor counts were unchanged, while plasma Flt3 ligand and VEGF only increased in the COPD patients. Plasma HGF levels were higher in the COPD patients compared with the controls and correlated inversely with the number of progenitor-derived colonies.

In conclusion, circulating CD34+ cells and endothelial progenitors were decreased in chronic obstructive pulmonary disease patients and could be correlated with disease severity.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
J. Grisar, C. W. Steiner, M. Bonelli, T. Karonitsch, I. Schwarzinger, G. Weigel, G. Steiner, and J. S. Smolen
Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells
Rheumatology, October 1, 2008; 47(10): 1476 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. T. van Beem, W. A. Noort, C. Voermans, M. Kleijer, A. ten Brinke, S. M. van Ham, C. E. van der Schoot, and J. J. Zwaginga
The Presence of Activated CD4+ T Cells Is Essential for the Formation of Colony-Forming Unit-Endothelial Cells by CD14+ Cells
J. Immunol., April 1, 2008; 180(7): 5141 - 5148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Asosingh, M. A. Aldred, A. Vasanji, J. Drazba, J. Sharp, C. Farver, S. A.A. Comhair, W. Xu, L. Licina, L. Huang, et al.
Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension
Am. J. Pathol., March 1, 2008; 172(3): 615 - 627.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera
Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?
Heart, January 1, 2008; 94(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. G. Barr, S. Mesia-Vela, J. H. M. Austin, R. C. Basner, B. M. Keller, A. P. Reeves, D. Shimbo, and L. Stevenson
Impaired Flow-mediated Dilation Is Associated with Low Pulmonary Function and Emphysema in Ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1200 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Diez, J. A. Barbera, E. Ferrer, R. Fernandez-Lloris, S. Pizarro, J. Roca, and V. I. Peinado
Plasticity of CD133+ cells: Role in pulmonary vascular remodeling
Cardiovasc Res, December 1, 2007; 76(3): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS, October 1, 2007; 4(7): 522 - 525.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Schatteman, M. Dunnwald, and C. Jiao
Biology of bone marrow-derived endothelial cell precursors
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. Gauldie, M. Kolb, K. Ask, G. Martin, P. Bonniaud, and D. Warburton
Smad3 Signaling Involved in Pulmonary Fibrosis and Emphysema
Proceedings of the ATS, November 1, 2006; 3(8): 696 - 702.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. I. Rennard, S. Togo, and O. Holz
Cigarette Smoke Inhibits Alveolar Repair: A Mechanism for the Development of Emphysema
Proceedings of the ATS, November 1, 2006; 3(8): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. A. Denburg and S. F. van Eeden
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
Eur. Respir. J., March 1, 2006; 27(3): 441 - 445.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.